Literature DB >> 10195046

Sexual transmission and prevention of the hepatitis viruses A-E and G.

M G Brook1.   

Abstract

OBJECTIVES: To assess current knowledge about the potential for sexual transmission of the hepatitis viruses A-E and G and how to prevent any such transmission.
METHOD: A search of published literature identified through Medline 1966-June 1998 (Ovid v 3.0), the Cochrane Library and reference lists taken from each article obtained. Textword and MeSH searches for hepatitis A, B, C, D, E, G, delta, GB virus, GBV-C were linked to searches under the textword terms sex$, vaccine$, prevent$, and MeSH subheadings, epidemiology, transmission, prevention, and control.
CONCLUSIONS: There is evidence for heterosexual transmission of hepatitis B, C, D, and G and homosexual transmission of hepatitis A-D and G. Condoms are an effective method for preventing transmission by penetrative vaginal or anal sex although spread of types A and B are linked also to oro-anal sex. Hepatitis types A and B can be prevented by pre- and post-exposure active or passive immunisation. There is still some uncertainty about appropriate target groups for pre-exposure vaccination, particularly against hepatitis A.

Entities:  

Mesh:

Year:  1998        PMID: 10195046      PMCID: PMC1758163          DOI: 10.1136/sti.74.6.395

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  55 in total

1.  An outbreak of hepatitis A among homosexual men in Amsterdam, 1991-1993.

Authors:  A Leentvaar-Kuijpers; J L Kool; P J Veugelers; R A Coutinho; G J van Griensven
Journal:  Int J Epidemiol       Date:  1995-02       Impact factor: 7.196

2.  Hepatitis E virus and HIV infection in homosexual men.

Authors:  F J Medrano; A Sanchez-Quijano; R Torronteras; M Leal; E Lissen
Journal:  Lancet       Date:  1995-01-14       Impact factor: 79.321

Review 3.  Clinical experience with an inactivated hepatitis A vaccine.

Authors:  R Clemens; A Safary; A Hepburn; C Roche; W J Stanbury; F E André
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

4.  The risks of transmission of acute hepatitis A and B virus infection in an urban centre.

Authors:  G Y Minuk; L X Ding; C Hannon; L Sekla
Journal:  J Hepatol       Date:  1994-07       Impact factor: 25.083

5.  A survey on hepatitis B vaccination policies in genitourinary medicine in UK and Ireland.

Authors:  A el-Dalil; K W Radcliffe; J Bailey; R A Richmond; A A Wade
Journal:  Genitourin Med       Date:  1995-08

6.  Impact of an intervention on HIV, sexually transmitted diseases, and condom use among sex workers in Bombay, India.

Authors:  G Bhave; C P Lindan; E S Hudes; S Desai; U Wagle; S P Tripathi; J S Mandel
Journal:  AIDS       Date:  1995-07       Impact factor: 4.177

7.  Epidemiology of hepatitis B infection in North America.

Authors:  M Kane
Journal:  Vaccine       Date:  1995       Impact factor: 3.641

8.  Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage.

Authors:  R J Gilson; A de Ruiter; J Waite; E Ross; C Loveday; D R Howell; R S Tedder; I V Weller
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

9.  Horizontal transmission of hepatitis B virus.

Authors:  P Van Damme; M Cramm; J C Van der Auwera; R Vranckx; A Meheus
Journal:  Lancet       Date:  1995-01-07       Impact factor: 79.321

10.  A community-wide outbreak of hepatitis A: risk factors for infection among homosexual and bisexual men.

Authors:  K J Henning; E Bell; J Braun; N D Barker
Journal:  Am J Med       Date:  1995-08       Impact factor: 4.965

View more
  2 in total

1.  Sexual health of homosexual men and women. Universal vaccination against hepatitis A cannot be firmly recommended for homosexual men.

Authors:  G Brook
Journal:  BMJ       Date:  1999-08-28

2.  The natural history of non-human GB virus C in captive chimpanzees.

Authors:  Emma L Mohr; Krishna K Murthy; James H McLinden; Jinhua Xiang; Jack T Stapleton
Journal:  J Gen Virol       Date:  2010-09-22       Impact factor: 3.891

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.